One could envision a short course of preoperative partial breast RT for a clinical early-stage, ER-positive, HER2-negative tumor, followed by a period of preoperative endocrine therapy, to allow time for the immune response to form; then the patient could undergo lumpectomy and lymph node sampling. This evidence concerns the gene ERBB2 and neoplasm.